Vireo Growth to Acquire Planet 13 in All-Stock Deal as Cannabis and Psychedelic Sectors See Major Moves

M&A · PartnershipEarnings Impact 4
โดย Yahoo Finance·Read original
Summary · why it matters

Vireo Growth Inc. agreed to acquire Planet 13 Holdings Inc. in an all-stock transaction, one of several major developments in the cannabis and psychedelic sectors this week. Under the deal, each Planet 13 share will be exchanged for 0.015383618 of a Vireo subordinate voting share, representing a 16.6% premium to Planet 13's 20-day volume-weighted average share price as of July 24, 2026. The acquisition will add 36 dispensaries, three cultivation and production facilities, a distribution license, and a cannabis consumption lounge license to Vireo's portfolio, and following this and previously announced acquisitions, Vireo expects to operate approximately 265 dispensaries across 15 states. Separately, SNDL Inc. completed its acquisition of key assets from U.S. cannabis operator Parallel, gaining control of 56 retail locations and three cultivation and manufacturing facilities in Florida, Texas, and Massachusetts, and now supports a 249-store cannabis retail network. Tilray Brands reported record fiscal 2026 net revenue of $915.5 million, an 11% increase from the prior year, while its annual net loss narrowed sharply to $105.2 million from nearly $2.2 billion. In the psychedelic sector, Eli Lilly and Company announced a deal worth up to $3.8 billion to acquire AtaiBeckley Inc., including an upfront cash payment valuing the company at approximately $2.8 billion and an additional $1 billion in contingent milestone payments. Clearmind Medicine reported positive safety results from Part A of its Phase I/II trial of CMND-100 for Alcohol Use Disorder, with all 24 healthy volunteers completing treatment and no serious adverse events reported.

Impact on stocks 5

Psychedelic Medicine▲ · 2 stocks
Health Care▲ · 2 stocks
Tilray Inc
TLRY
▲ PositiveCapitalrelevance

Record fiscal 2026 net revenue of $915.5 million, up 11%, and narrowed net loss.

Biotech & Genomic Medicine▲ · 1 stocks
Eli Lilly and Company
LLY
▲ PositiveCapitalrelevance

Announced acquisition of AtaiBeckley for up to $3.8 billion, expanding psychedelic portfolio.

Off-coverage companies 2

Planet 13 Holdings Inc.Private▲ Positive
Capitalrelevance

Acquired by Vireo at a 16.6% premium to Planet 13's 20-day VWAP.

Vireo Growth Inc.Private▲ Positive
Capitalrelevance

Agreed to acquire Planet 13 in all-stock deal, adding 36 dispensaries and expanding footprint.

© 2026 MarketDXNews